Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • G. Eisenhofer - , Department of Internal Medicine III, Institute of Clinical Chemistry and Laboratory Medicine (Author)
  • S. Brown - , Department of Neurology (Author)
  • M. Peitzsch - , Institute of Clinical Chemistry and Laboratory Medicine (Author)
  • D. Pelzel - , Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • P. Lattke - , Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • S. Glöckner - , Department of Internal Medicine 3, University of Melbourne (Author)
  • A. Stell - , University of Melbourne (Author)
  • A. Prejbisz - , National Institute of Cardiology, Warszawa (Author)
  • M. Fassnacht - , University Hospital of Würzburg, Hospital of the Ludwig-Maximilians-University (LMU) Munich (Author)
  • F. Beuschlein - , Hospital of the Ludwig-Maximilians-University (LMU) Munich (Author)
  • A. Januszewicz - , National Institute of Cardiology, Warszawa (Author)
  • G. Siegert - , Institute for Clinical Chemistry and Laboratory Medicine (Author)
  • Heinz Reichmann - , Department of Neurology (Author)

Details

Original languageEnglish
Pages (from-to)38-46
Number of pages9
JournalAnnals of clinical biochemistry
Volume51
Issue number1
Publication statusPublished - 2013
Peer-reviewedYes

External IDs

Scopus 84894566663

Keywords